-transparent.png){kind=logo}
1,25-Dihydroxyvitamin D3 [1,25(OH)2 D3] may be an immunomodulatory drug which could have a role in controlling collagen deposition, and inducing reversal of fibrosis in some tissues. These observations prompted a study of the possible use of this hormone for the treatment of scleroderma. A 35-year-old woman, who had been suffering from localized scleroderma for 2 years, was given oral 1,25(OH)2 D3 for 6 months. The effects of the treatment were evaluated using clinical and physical measurements (skin thickness, extensibility properties of the skin). The evolution of the patient's condition during the 6-month therapy suggests that 1,25(OH)2 D3 is beneficial in localized scleroderma. The mechanisms of action are discussed in relation to the literature, which suggests both immunoregulatory and inhibitory effects on fibroblast growth.
P G Humbert, and
J L Dupond, and
A Rochefort, and
R Vasselet, and
A Lucas, and
R Laurent, and
P Agache
May 1994,
The Journal of biological chemistry,
P G Humbert, and
J L Dupond, and
A Rochefort, and
R Vasselet, and
A Lucas, and
R Laurent, and
P Agache
March 2013,
The Journal of clinical endocrinology and metabolism,
P G Humbert, and
J L Dupond, and
A Rochefort, and
R Vasselet, and
A Lucas, and
R Laurent, and
P Agache
January 2014,
PloS one,
P G Humbert, and
J L Dupond, and
A Rochefort, and
R Vasselet, and
A Lucas, and
R Laurent, and
P Agache
December 1989,
Proceedings of the National Academy of Sciences of the United States of America,
P G Humbert, and
J L Dupond, and
A Rochefort, and
R Vasselet, and
A Lucas, and
R Laurent, and
P Agache
July 2007,
Veterinary journal (London, England : 1997),
P G Humbert, and
J L Dupond, and
A Rochefort, and
R Vasselet, and
A Lucas, and
R Laurent, and
P Agache
March 1985,
Biochemical and biophysical research communications,
P G Humbert, and
J L Dupond, and
A Rochefort, and
R Vasselet, and
A Lucas, and
R Laurent, and
P Agache
September 1983,
The Biochemical journal,
P G Humbert, and
J L Dupond, and
A Rochefort, and
R Vasselet, and
A Lucas, and
R Laurent, and
P Agache
March 1974,
Science (New York, N.Y.),
P G Humbert, and
J L Dupond, and
A Rochefort, and
R Vasselet, and
A Lucas, and
R Laurent, and
P Agache
June 1984,
Lancet (London, England),
P G Humbert, and
J L Dupond, and
A Rochefort, and
R Vasselet, and
A Lucas, and
R Laurent, and
P Agache
April 1984,
Physiological reviews,
